Compare $ACTU vs $CNSY | Chartloom

Compare

$ACTU vs $CNSY

Actuate Therapeutics Inc · Plus Therapeutics Inc

ACTU

Actuate Therapeutics Inc

CNSY

Plus Therapeutics Inc

Compare $ACTU vs $CNSY

Comparing Actuate Therapeutics Inc and Plus Therapeutics Inc

ACTUActuate Therapeutics Inc

CNSYPlus Therapeutics Inc

ACTUActuate Therapeutics Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-89.9%

52W performance

-91.3%

FCF yield

-135.8%

CNSYPlus Therapeutics Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.12x

Rev growth (TTM)

—

YTD performance

-45.2%

52W performance

-45.2%

FCF yield

-267.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACTU

CNSY

Detailed metrics comparison

ACTU

Actuate Therapeutics Inc

CNSY

Plus Therapeutics Inc

Market Cap

ACTU$15M

CNSY$13M

Enterprise Value

ACTU$11M

CNSY$11M

Price

ACTU$0.61

CNSY$1.93

P/E Ratio

ACTUN/A

CNSYN/A

P/S Ratio

ACTU0.00x

CNSY3.16x

EV/Sales

ACTU0.00x

CNSY2.60x

EV/EBITDA

ACTU0.00x

CNSY0.00x

P/B Ratio

ACTU19.88x

CNSY2.22x

P/FCF Ratio

ACTUN/A

CNSYN/A

EV/FCF

ACTU-0.53x

CNSY-0.31x

PEG Ratio

ACTUN/A

CNSYN/A

Forward P/E (NTM)

ACTUN/A

CNSYN/A

Forward P/S (NTM)

ACTUN/A

CNSY1.12x

Revenue (TTM)

ACTU$0

CNSY$4M

Revenue Growth (YoY)

ACTUN/A

CNSYN/A

Forward Rev Growth

ACTU50.1%

CNSY216.6%

Gross Margin (TTM)

ACTU0.0%

CNSY0.0%

Operating Margin (TTM)

ACTU0.0%

CNSY0.0%

EBITDA Margin (TTM)

ACTU0.0%

CNSY-612.0%

Net Margin (TTM)

ACTU0.0%

CNSY-620.7%

FCF Margin (TTM)

ACTUN/A

CNSY-845.3%

Net Income (TTM)

ACTU$-20M

CNSY$-26M

FCF (TTM)

ACTU$-20M

CNSY$-36M

EPS (TTM)

ACTU-$0.86

CNSY-$3.78

ROE (TTM)

ACTU-34618.0%

CNSY-39417.0%

ROA (TTM)

ACTU-17840.0%

CNSY-15136.0%

ROIC (TTM)

ACTU-32397.0%

CNSY-37414.0%

Cash

ACTU$4M

CNSY$2M

Debt

ACTU$405K

CNSY$0

Net Cash/Debt

ACTU$4M

CNSY$2M

Current Ratio (TTM)

ACTU1.25x

CNSY1.37x

Quick Ratio (TTM)

ACTU1.16x

CNSY1.26x

Debt/Equity (TTM)

ACTU0.41x

CNSY0.19x

Debt/Assets (TTM)

ACTU0.0%

CNSY0.0%

Interest Coverage (TTM)

ACTUN/A

CNSYN/A

Net Debt/EBITDA (TTM)

ACTU0.00x

CNSY0.00x

Beta

ACTU1.66

CNSY2.21

52W Performance

ACTU-91.3%

CNSY-45.2%

YTD Performance

ACTU-89.9%

CNSY-45.2%

% from 52W High

ACTU-92.8%

CNSY-53.6%

% from 52W Low

ACTU1.0%

CNSY30.0%

Asset Turnover (TTM)

ACTU0.00x

CNSY0.24x

FCF Yield (TTM)

ACTU-135.8%

CNSY-267.6%

Earnings Yield (TTM)

ACTU-140.1%

CNSY-196.5%

Dividend Yield (TTM)

ACTUN/A

CNSYN/A

Rule of 40

ACTU0.0

CNSY-845.3

EV/GP/RG

ACTUN/A

CNSYN/A

Ticker research

View ACTU research View CNSY research

Metric	ACTU Actuate Therapeutics Inc	CNSY Plus Therapeutics Inc
Market & Valuation
Market Cap	$15M	$13M
Enterprise Value	$11M	$11M
Price	$0.61	$1.93
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.16x
EV/Sales	0.00x	2.60x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.88x	2.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.53x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.12x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	50.1%	216.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-612.0%
Net Margin (TTM)	0.0%	-620.7%
FCF Margin (TTM)	N/A	-845.3%
Net Income (TTM)	$-20M	$-26M
FCF (TTM)	$-20M	$-36M
EPS (TTM)	-$0.86	-$3.78
ROE (TTM)	-34618.0%	-39417.0%
ROA (TTM)	-17840.0%	-15136.0%
ROIC (TTM)	-32397.0%	-37414.0%
Financial Health
Cash	$4M	$2M
Debt	$405K	$0
Net Cash/Debt	$4M	$2M
Current Ratio (TTM)	1.25x	1.37x
Quick Ratio (TTM)	1.16x	1.26x
Debt/Equity (TTM)	0.41x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	2.21
52W Performance	-91.3%	-45.2%
YTD Performance	-89.9%	-45.2%
% from 52W High	-92.8%	-53.6%
% from 52W Low	1.0%	30.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.24x
FCF Yield (TTM)	-135.8%	-267.6%
Earnings Yield (TTM)	-140.1%	-196.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-845.3
EV/GP/RG	N/A	N/A
Ticker research	View ACTU research	View CNSY research

Valuation

P/S Ratio

ACTU

0.00x

CNSY

3.16x

EV/FCF

ACTU

-0.53x

CNSY

-0.31x

Growth & revenue

Forward Revenue Growth

CNSY

216.6%

ACTU

50.1%

Profitability & performance

Gross Margin

ACTU

0.0%

CNSY

0.0%

ROE

ACTU

-34618.0%

CNSY

-39417.0%

FCF Yield %

ACTU

-135.8%

CNSY

-267.6%

52-Week Performance

CNSY

-45.2%

ACTU

-91.3%

Detailed metrics comparison

ACTU

Actuate Therapeutics Inc

CNSY

Plus Therapeutics Inc

Market Cap

ACTU$15M

CNSY$13M

Enterprise Value

ACTU$11M

CNSY$11M

Price

ACTU$0.61

CNSY$1.93

P/E Ratio

ACTUN/A

CNSYN/A

P/S Ratio

ACTU0.00x

CNSY3.16x

EV/Sales

ACTU0.00x

CNSY2.60x

EV/EBITDA

ACTU0.00x

CNSY0.00x

P/B Ratio

ACTU19.88x

CNSY2.22x

P/FCF Ratio

ACTUN/A

CNSYN/A

EV/FCF

ACTU-0.53x

CNSY-0.31x

PEG Ratio

ACTUN/A

CNSYN/A

Forward P/E (NTM)

ACTUN/A

CNSYN/A

Forward P/S (NTM)

ACTUN/A

CNSY1.12x

Revenue (TTM)

ACTU$0

CNSY$4M

Revenue Growth (YoY)

ACTUN/A

CNSYN/A

Forward Rev Growth

ACTU50.1%

CNSY216.6%

Gross Margin (TTM)

ACTU0.0%

CNSY0.0%

Operating Margin (TTM)

ACTU0.0%

CNSY0.0%

EBITDA Margin (TTM)

ACTU0.0%

CNSY-612.0%

Net Margin (TTM)

ACTU0.0%

CNSY-620.7%

FCF Margin (TTM)

ACTUN/A

CNSY-845.3%

Net Income (TTM)

ACTU$-20M

CNSY$-26M

FCF (TTM)

ACTU$-20M

CNSY$-36M

EPS (TTM)

ACTU-$0.86

CNSY-$3.78

ROE (TTM)

ACTU-34618.0%

CNSY-39417.0%

ROA (TTM)

ACTU-17840.0%

CNSY-15136.0%

ROIC (TTM)

ACTU-32397.0%

CNSY-37414.0%

Cash

ACTU$4M

CNSY$2M

Debt

ACTU$405K

CNSY$0

Net Cash/Debt

ACTU$4M

CNSY$2M

Current Ratio (TTM)

ACTU1.25x

CNSY1.37x

Quick Ratio (TTM)

ACTU1.16x

CNSY1.26x

Debt/Equity (TTM)

ACTU0.41x

CNSY0.19x

Debt/Assets (TTM)

ACTU0.0%

CNSY0.0%

Interest Coverage (TTM)

ACTUN/A

CNSYN/A

Net Debt/EBITDA (TTM)

ACTU0.00x

CNSY0.00x

Beta

ACTU1.66

CNSY2.21

52W Performance

ACTU-91.3%

CNSY-45.2%

YTD Performance

ACTU-89.9%

CNSY-45.2%

% from 52W High

ACTU-92.8%

CNSY-53.6%

% from 52W Low

ACTU1.0%

CNSY30.0%

Asset Turnover (TTM)

ACTU0.00x

CNSY0.24x

FCF Yield (TTM)

ACTU-135.8%

CNSY-267.6%

Earnings Yield (TTM)

ACTU-140.1%

CNSY-196.5%

Dividend Yield (TTM)

ACTUN/A

CNSYN/A

Rule of 40

ACTU0.0

CNSY-845.3

EV/GP/RG

ACTUN/A

CNSYN/A

Ticker research

View ACTU research View CNSY research

Metric	ACTU Actuate Therapeutics Inc	CNSY Plus Therapeutics Inc
Market & Valuation
Market Cap	$15M	$13M
Enterprise Value	$11M	$11M
Price	$0.61	$1.93
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.16x
EV/Sales	0.00x	2.60x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.88x	2.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.53x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.12x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	50.1%	216.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-612.0%
Net Margin (TTM)	0.0%	-620.7%
FCF Margin (TTM)	N/A	-845.3%
Net Income (TTM)	$-20M	$-26M
FCF (TTM)	$-20M	$-36M
EPS (TTM)	-$0.86	-$3.78
ROE (TTM)	-34618.0%	-39417.0%
ROA (TTM)	-17840.0%	-15136.0%
ROIC (TTM)	-32397.0%	-37414.0%
Financial Health
Cash	$4M	$2M
Debt	$405K	$0
Net Cash/Debt	$4M	$2M
Current Ratio (TTM)	1.25x	1.37x
Quick Ratio (TTM)	1.16x	1.26x
Debt/Equity (TTM)	0.41x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	2.21
52W Performance	-91.3%	-45.2%
YTD Performance	-89.9%	-45.2%
% from 52W High	-92.8%	-53.6%
% from 52W Low	1.0%	30.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.24x
FCF Yield (TTM)	-135.8%	-267.6%
Earnings Yield (TTM)	-140.1%	-196.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-845.3
EV/GP/RG	N/A	N/A
Ticker research	View ACTU research	View CNSY research